Clinical efficacy and safety of combination of abraxane and trastuzumab in treatment of recurrent ovarian cancer

Yi Yang; Zhi-shun Lu; Zhu Zeng

doi:10.36721/pjps/31/6(Special)/06.11.2018/6724/2831-2834

original articles

Clinical efficacy and safety of combination of abraxane and trastuzumab in treatment of recurrent ovarian cancer

Yi Yang, Zhi-shun Lu, Zhu Zeng

Vol. 31

Issue 6

Pages 2831-2834

Published 29 Nov 2018

DOI: 10.36721/pjps/31/6(Special)/06.11.2018/6724/2831-2834

Authors Abstract Related

Authors & Affiliations

Yi Yang

Zhi-shun Lu

Zhu Zeng

Abstract

Present research work is carried out to compare the clinical efficacy and adverse reactions between combined medication

Keywords

Recurrent

ovarian cancer

abraxane

trastuzumab

Metrics

PlumX Metrics

original articles

Clinical efficacy and safety of combination of abraxane and trastuzumab in treatment of recurrent ovarian cancer

Yi Yang, Zhi-shun Lu, Zhu Zeng

Vol. 31

Issue 6

Pages 2831-2834

Published 29 Nov 2018

DOI: 10.36721/pjps/31/6(Special)/06.11.2018/6724/2831-2834

Authors Abstract Related

Authors & Affiliations

Yi Yang

Zhi-shun Lu

Zhu Zeng

Abstract

Present research work is carried out to compare the clinical efficacy and adverse reactions between combined medication

Keywords

Recurrent

ovarian cancer

abraxane

trastuzumab

Metrics

PlumX Metrics

Clinical efficacy and safety of combination of abraxane and trastuzumab in treatment of recurrent ovarian cancer

Authors & Affiliations

Abstract

Keywords

Metrics

Indexed & Abstracted in Leading Databases

Clinical efficacy and safety of combination of abraxane and trastuzumab in treatment of recurrent ovarian cancer

Authors & Affiliations

Abstract

Keywords

Metrics